{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:44:00Z","timestamp":1792511040695,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00228-021-03177-y","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T07:02:39Z","timestamp":1627714959000},"page":"1815-1823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis"],"prefix":"10.1007","volume":"77","author":[{"given":"Mingwen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianlian","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inam","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuchu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samee","family":"Abdus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-7570","authenticated-orcid":false,"given":"Chunjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"issue":"11","key":"3177_CR1","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Munoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B (2019) 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation 140(11):e596\u2013e646. https:\/\/doi.org\/10.1161\/CIR.0000000000000678","journal-title":"Circulation"},{"issue":"2","key":"3177_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Group ESCSD","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Group ESCSD (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394","journal-title":"Eur Heart J"},{"key":"3177_CR3","doi-asserted-by":"publisher","unstructured":"Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ (2018) ACC\/AHA versus ESC guidelines on dual antiplatelet therapy: JACC Guideline Comparison. J Am Coll Cardiol 72 (23 Pt A): 2915\u20132931.\u00a0https:\/\/doi.org\/10.1016\/j.jacc.2018.09.057","DOI":"10.1016\/j.jacc.2018.09.057"},{"key":"3177_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clinbiochem.2018.12.009","volume":"64","author":"B Hg","year":"2019","unstructured":"Binderup HG, Houlind K, Brasen CL, Madsen JS\u00a0(2019) Identification of aspirin resistance using a PDW-miR92a-score: Validation in an intermittent claudication cohort. Clin Biochem 64:30\u201336. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.12.009","journal-title":"Clin Biochem"},{"issue":"4","key":"3177_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-2007-996108","volume":"23","author":"K S,","year":"1997","unstructured":"\u00a0Schr\u00f6r K\u00a0(1997) Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 23(4):349\u2013356. https:\/\/doi.org\/10.1055\/s-2007-996108","journal-title":"Semin Thromb Hemost"},{"issue":"16","key":"3177_CR6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","volume":"379","author":"L Bowman","year":"2018","unstructured":"Group ASC, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, Murphy K, Aung T, Haynes R, Cox J, Murawska A, Young A, Lay M, Chen F, Sammons E, Waters E, Adler A, Bodansky J, Farmer A, McPherson R, Neil A, Simpson D, Peto R, Baigent C, Collins R, Parish S, Armitage J (2018) Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med 379(16):1529\u20131539. https:\/\/doi.org\/10.1056\/NEJMoa1804988","journal-title":"N Engl J Med"},{"issue":"7","key":"3177_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1046\/j.1365-2036.2001.01016.x","volume":"15","author":"L Rj","year":"2001","unstructured":"Laheij RJ, Jansen JB, Verbeek AL, Verheugt FW\u00a0(2001) Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease. Aliment Pharmacol Ther 15(7):1055\u20131059. https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01016.x","journal-title":"Aliment Pharmacol Ther"},{"key":"3177_CR8","unstructured":"Devillier P (2001) [Pharmacology of non-steroidal anti-inflammatory drugs and ENT pathology]. Presse medicale (Paris, France : 1983) 30(39-40 Pt 2):70\u201379"},{"key":"3177_CR9","doi-asserted-by":"publisher","unstructured":"Liu J, Xu D, Xia N, Hou K, Chen S, Wang Y, Li Y (2018) Anticoagulant activities of indobufen, an antiplatelet drug. Molecules (Basel, Switzerland) 23(6):1452. https:\/\/doi.org\/10.3390\/molecules23061452","DOI":"10.3390\/molecules23061452"},{"issue":"3","key":"3177_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/09537104.2012.686072","volume":"24","author":"F B, FM P, E M, C T, G T, T D, M P,","year":"2013","unstructured":"Barill\u00e0 F, Pulcinelli FM, Mangieri E, Torromeo C, Tanzilli G, Dominici T, Pellicano M, Paravati V, Acconcia MC, Gaudio C\u00a0(2013) Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. Platelets 24(3):183\u2013188. https:\/\/doi.org\/10.3109\/09537104.2012.686072","journal-title":"Platelets"},{"issue":"2","key":"3177_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00045391-200403000-00004","volume":"11","author":"A M, S C, I F, A G, DT L,","year":"2004","unstructured":"Marzo A, Crestani S, Fumagalli I, Giusti A, Lowenthal DT (2004) Endoscopic evaluation of the effects of indobufen and aspirin in healthy volunteers. Am J Ther 11(2):98\u2013102. https:\/\/doi.org\/10.1097\/00045391-200403000-00004","journal-title":"Am J Ther"},{"issue":"1","key":"3177_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3760\/cma.j.issn.0253-3758.2018.01.004","volume":"46","author":"T Force","year":"2018","unstructured":"Task Force on Chinese Guidelines for the Prevention of Cardiovascular D, Editorial Board of Chinese Journal of C, (2018) [Chinese guidelines for the prevention of cardiovascular diseases(2017)]. Zhonghua Xin Xue Guan Bing Za Zhi 46(1):10\u201325. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3758.2018.01.004","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"23","key":"3177_CR13","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.jacc.2008.08.047","volume":"52","author":"J S, EH M, S C, E M-S,","year":"2008","unstructured":"Saw J, Madsen EH, Chan S, Maurer-Spurej E\u00a0(2008) The ELAPSE (evaluation of long-term clopidogrel antiplatelet and systemic anti-inflammatory effects) study. J Am Coll Cardiol 52(23):1826\u20131833.\u00a0https:\/\/doi.org\/10.1016\/j.jacc.2008.08.047","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3177_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1538-7836.2012.04641.x","volume":"10","author":"C Li","year":"2012","unstructured":"Li C, Hirsh J, Xie C, Johnston MA, Eikelboom JW (2012) Reversal of the anti-platelet effects of aspirin and clopidogrel. J Thromb Haemost 10(4):521\u2013528. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04641.x","journal-title":"J Thromb Haemost"},{"issue":"23","key":"3177_CR15","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/circulationaha.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123(23):2736\u20132747. https:\/\/doi.org\/10.1161\/circulationaha.110.009449","journal-title":"Circulation"},{"issue":"14","key":"3177_CR16","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1161\/01.cir.0000013777.21160.07","volume":"105","author":"J Eikelboom","year":"2002","unstructured":"Eikelboom J, Hirsh J, Weitz J, Johnston M, Yi Q, Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105(14):1650\u20131655. https:\/\/doi.org\/10.1161\/01.cir.0000013777.21160.07","journal-title":"Circulation"},{"key":"3177_CR17","doi-asserted-by":"publisher","unstructured":"Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezzari M, Pamparana F, Coccheri S (1997) Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. Stroke 28(5):1015-1021.\u00a0https:\/\/doi.org\/10.1161\/01.str.28.5.1015","DOI":"10.1161\/01.str.28.5.1015"},{"issue":"16","key":"3177_CR18","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1073\/pnas.83.16.5861","volume":"83","author":"F Catella","year":"1986","unstructured":"Catella F, Healy D, Lawson J, FitzGerald G (1986) 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci USA 83(16):5861\u20135865. https:\/\/doi.org\/10.1073\/pnas.83.16.5861","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3177_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.thromres.2006.11.012","volume":"120","author":"P Harrison","year":"2007","unstructured":"Harrison P, Frelinger A, Furman M, Michelson A (2007) Measuring antiplatelet drug effects in the laboratory. Thromb Res 120(3):323\u2013336. https:\/\/doi.org\/10.1016\/j.thromres.2006.11.012","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"3177_CR20","doi-asserted-by":"publisher","first-page":"A22","DOI":"10.1136\/heartjnl-2014-307109.6","volume":"101","author":"T Liu","year":"2015","unstructured":"Liu T, Zhang J, Chen Y, Feng X, Wang L, Liu M (2015) ASSA14-03-38 Comparison of urinary11-dehydrothromboxaneB2 detection and plasma LTA assay for evaluating aspirin response in the Aged Patients with Coronary Artery Disease. Heart 101(Suppl 1):A22\u2013A22.\u00a0https:\/\/doi.org\/10.1136\/heartjnl-2014-307109.56","journal-title":"Heart"},{"issue":"2","key":"3177_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000342489","volume":"59","author":"L Fan","year":"2013","unstructured":"Fan L, Cao J, Liu L, Li X, Hu G, Hu Y, Zhu B (2013) Frequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular disease. Gerontology 59(2):122\u2013131. https:\/\/doi.org\/10.1159\/000342489","journal-title":"Gerontology"},{"issue":"12","key":"3177_CR22","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2017.07.743","volume":"70","author":"D P, C N, A F, S B, M S, F V, R C,","year":"2017","unstructured":"Pastori D, Nocella C, Farcomeni A, Bartimoccia S, Santulli M, Vasaturo F, Carnevale R, Menichelli D, Violi F, Pignatelli P (2017) Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation. J Am Coll Cardiol 70(12):1455\u20131462.\u00a0https:\/\/doi.org\/10.1016\/j.jacc.2017.07.743","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3177_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/09537104.2015.1042853","volume":"27","author":"L Jy","year":"2016","unstructured":"Lee JY, Sung KC, Choi HI (2016) Comparison of aspirin and indobufen in healthy volunteers. Platelets 27(2):105\u2013109.\u00a0https:\/\/doi.org\/10.3109\/09537104.2015.1042853","journal-title":"Platelets"},{"issue":"4","key":"3177_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/01.cir.96.4.1109","volume":"96","author":"F Cipollone","year":"1997","unstructured":"Cipollone F, Patrignani P, Greco A, Panara M, Padovano R, Cuccurullo F, Patrono C, Rebuzzi A, Liuzzo G, Quaranta G, Maseri A (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 96(4):1109\u20131116. https:\/\/doi.org\/10.1161\/01.cir.96.4.1109","journal-title":"Circulation"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03177-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T06:04:25Z","timestamp":1636610665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03177-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3177"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03177-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,31]]},"assertion":[{"value":"7 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (Approval Number2017-SR-226).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All enrolled subjects signed the informed consent form (ICF) before the study was conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All co-authors have reviewed and approved this manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Chunjian Li received the donation of indobufen from Huadong Medicine Co., Ltd., China.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}